Can AI help close a persistent gap in cardiovascular care?
An exploration of a persistent demographic gap in cardiovascular care (under diagnosis in women) and the way AI is being used to try to close the gap.
At a glance
Read on to get our full commentary, or use the links below to jump to a specific area of interest:
-
Drivers of the underdiagnosis problem in women
-
Solutions that have been tried—and failed to completely solve
-
What’s different about AI-driven approaches to closing cardiovascular care gaps
-
Three keys to changing the default approach in cardiovascular care
-
Spotlight on the AHA’s investment in Ultromics
-
Summary
This week, we’re running a Strategy Bootcamp on cardiovascular (CV) care because no matter where Union members sit in the ecosystem—health systems, payers, employers, digital health, devices, or investing—you can’t make smart decisions in healthcare without a working grasp of cardiovascular services. It’s one of the biggest spend categories, one of the most operationally complex service lines, and one of the fastest-moving markets in terms of policy, innovation, and site-of-care shifts.
As I worked on this project, two related dynamics stood out to me: A longstanding clinical standardization problem, and a new potential AI solution set. This pair is well-known to CV insiders, but might be flying under the radar for those who don’t work day-to-day with this clinical area.
- The persistent clinical standardization problem: Women are more likely to present “atypically,” later, and be underdiagnosed for common and serious cardiovascular conditions. People who live in this world know the pattern and have been trying to correct it forever using clinical standardization and public communication levers. The challenge is that the pattern stubbornly remains—we have yet to see equal detection, more effective pathways, or better outcomes.
- A new AI solution?: There’s a real push underway to use AI-enabled diagnostics to help close that gap, through better pattern recognition, earlier risk identification, and more consistent interpretation of signals that humans can miss under time pressure. This is striking to me because it’s so common to talk about AI as a potential source of bias. This case helps illustrate the flip side: a growing share of innovation in clinical AI is explicitly aimed at reducing bias, by standardizing detection and catching risk earlier across populations that have historically been missed.
Union Healthcare Insight
Log in to continue reading
Not a member yet? Create a free account for limited access.
Related insights
Healthcare’s next forced efficiency leap is AI. Where does your organization stand?
The health-system utilization forecasting conundrum: One size definitely doesn’t fit all.
Key takeaways from our Chicago Revenue Cycle Summit